AF is associated with increased rates of stroke, heart failure, and mortality. Lifestyle and risk factor modification are recommended to prevent AF onset, recurrence, and complications, and oral anticoagulants are recommended for those with an estimated risk of stroke or thromboembolic events of 2% or greater per year. Early rhythm control using antiarrhythmic drugs or catheter ablation is recommended in select patients with AF experiencing symptomatic paroxysmal AF or HFrEF.
Professor Gregory Lip, Marco Proietti, Tatjana Potpara, Moussa Mansour, Irina Savelieva, Hung‐Fat Tse, Andreas Goette, A. John Camm, Carina Blomström‐Lundqvist, Dhiraj Gupta, Giuseppe Boriani
Annabelle Santos Volgman, Emelia Benjamin, Anne B. Curtis, Margaret C. Fang, Kathryn J. Lindley, Gerald V. Naccarelli, Carl J. Pepine, Odayme Quesada, Marmar Vaseghi, Albert L. Waldo, Nanette K. Wenger, Andrea M. Russo
Discussion(0)
No comments yet. Be the first to comment.